4//SEC Filing
Nark Ted C 4
Accession 0000899243-20-012261
CIK 0001723128other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 5:25 PM ET
Size
13.7 KB
Accession
0000899243-20-012261
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2020-05-07+6,459→ 62,566 total - Award
Restricted Stock Units
2020-05-05+46,218→ 46,218 total→ Class A Common Stock (46,218 underlying) - Exercise/Conversion
Restricted Stock Units
2020-05-07−6,459→ 0 total→ Class A Common Stock (6,459 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
- [F3]On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020.
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001316851
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 5:25 PM ET
- Size
- 13.7 KB